Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2026-01-24 @ 11:13 PM
Study NCT ID:
NCT01095120
Status:
UNKNOWN
Last Update Posted:
2012-03-15
First Post:
2010-03-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer
Sponsor:
Genta Incorporated
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TOG201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None